These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance. Zufan SE; Lau KA; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson WD; Ballard SA; Stinear TP; Howden BP; Jennison AV; Seemann T Microb Genom; 2023 Nov; 9(11):. PubMed ID: 38019123 [TBL] [Abstract][Full Text] [Related]
4. Whole-genome sequencing for antimicrobial surveillance: species-specific quality thresholds and data evaluation from the network of the European Union Reference Laboratory for Antimicrobial Resistance genomic proficiency tests of 2021 and 2022. Sørensen LH; Pedersen SK; Jensen JD; Lacy-Roberts N; Andrea A; S M Brouwer M; Veldman KT; Lou Y; Hoffmann M; S Hendriksen R mSystems; 2024 Sep; 9(9):e0016024. PubMed ID: 39105591 [TBL] [Abstract][Full Text] [Related]
5. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories. Lau KA; Kaufer A; Gray J; Theis T; Rawlinson WD Pathology; 2022 Jun; 54(4):472-478. PubMed ID: 35440366 [TBL] [Abstract][Full Text] [Related]
7. Efficient SARS-CoV-2 Surveillance during the Pandemic-Endemic Transition Using PCR-Based Genotyping Assays. Koets L; van Leeuwen K; Derlagen M; van Wijk J; Keijzer N; Feenstra JDM; Gandhi M; Sorel O; van de Laar TJW; Koppelman MHGM Microbiol Spectr; 2023 Jun; 11(3):e0345022. PubMed ID: 37154727 [TBL] [Abstract][Full Text] [Related]
8. Benchmark datasets for SARS-CoV-2 surveillance bioinformatics. Xiaoli L; Hagey JV; Park DJ; Gulvik CA; Young EL; Alikhan NF; Lawsin A; Hassell N; Knipe K; Oakeson KF; Retchless AC; Shakya M; Lo CC; Chain P; Page AJ; Metcalf BJ; Su M; Rowell J; Vidyaprakash E; Paden CR; Huang AD; Roellig D; Patel K; Winglee K; Weigand MR; Katz LS PeerJ; 2022; 10():e13821. PubMed ID: 36093336 [TBL] [Abstract][Full Text] [Related]
9. Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories. Lau KA; Gonçalves da Silva A; Theis T; Gray J; Ballard SA; Rawlinson WD Pathology; 2021 Dec; 53(7):902-911. PubMed ID: 34274166 [TBL] [Abstract][Full Text] [Related]
10. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study. Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439 [TBL] [Abstract][Full Text] [Related]
11. Rapid, high-throughput, cost-effective whole-genome sequencing of SARS-CoV-2 using a condensed library preparation of the Illumina DNA Prep kit. Hickman R; Nguyen J; Lee TD; Tyson JR; Azana R; Tsang F; Hoang L; Prystajecky NA J Clin Microbiol; 2024 Mar; 62(3):e0010322. PubMed ID: 38315007 [TBL] [Abstract][Full Text] [Related]
12. Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory. Lind A; Barlinn R; Landaas ET; Andresen LL; Jakobsen K; Fladeby C; Nilsen M; Bjørnstad PM; Sundaram AYM; Ribarska T; Müller F; Gilfillan GD; Holberg-Petersen M J Clin Virol; 2021 Aug; 141():104906. PubMed ID: 34273860 [TBL] [Abstract][Full Text] [Related]
13. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis. Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
15. Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program. Jung A; Droit L; Febles B; Fronick C; Cook L; Handley SA; Parikh BA; Wang D Microbiol Spectr; 2024 Aug; 12(8):e0422523. PubMed ID: 38912809 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years. Khairnar K; Tomar SS Virus Res; 2024 Jun; 344():199365. PubMed ID: 38527669 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis. Coolen JPM; Wolters F; Tostmann A; van Groningen LFJ; Bleeker-Rovers CP; Tan ECTH; van der Geest-Blankert N; Hautvast JLA; Hopman J; Wertheim HFL; Rahamat-Langendoen JC; Storch M; Melchers WJG J Clin Virol; 2021 Nov; 144():104993. PubMed ID: 34619382 [TBL] [Abstract][Full Text] [Related]
18. Development and application of proficiency testing (PT) to evaluate the diagnostic capacity of SARS-CoV-2 by RT-qPCR - A practical and metrological approach. Rodrigues CO; Olivares IRB; Reischak D; Catozzi MB; Cardoso FG; Pinhel MFM Diagn Microbiol Infect Dis; 2023 Oct; 107(2):116021. PubMed ID: 37506595 [TBL] [Abstract][Full Text] [Related]
19. Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern. Pinkhover NP; Pontbriand KM; Fletcher KP; Sanchez E; Okello K; Garvey LM; Pum A; Li K; DeOliveira G; Proctor T; Feenstra JDM; Sorel O; Gandhi M; Auclair JR Microbiol Spectr; 2024 Feb; 12(2):e0348423. PubMed ID: 38206048 [TBL] [Abstract][Full Text] [Related]
20. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]